The chemical substance known as "2-[(6-methoxy-4-methylquinazolin-2-yl)amino]-6-{[(1-phenyl-1H-tetrazol-5-yl)sulfanyl]methyl}pyrimidin-4(3H)-one," with the CAS number 669749-45-5, is a complex organic compound characterized by its multi-ring structure, which includes a quinazoline and a pyrimidinone moiety. This compound features various functional groups, including an amino group, a methoxy group, and a sulfanyl group, contributing to its potential biological activity. The presence of the tetrazole ring suggests possible interactions with biological targets, making it of interest in medicinal chemistry. Its molecular structure indicates potential for diverse pharmacological properties, including anti-cancer or anti-inflammatory activities, although specific biological effects would depend on further empirical studies. The compound's solubility, stability, and reactivity would be influenced by its functional groups and overall molecular architecture, which are critical for its application in drug development and research.

DCE_42 is a novel EZH2 inhibitor that also displays significant anti-proliferation activity against lymphoma cell lines.

2-[(6-methoxy-4-methylquinazolin-2-yl)amino]-6-{[(1-phenyl-1H-tetrazol-5-yl)sulfanyl]methyl}pyrimidin-4(3H)-one

669749-45-5: The chemical substance known as "2-[(6-methoxy-4-methylquinazolin-2-yl)amino]-6-{[(1-phenyl-1H-tetrazol-5-yl)sulfanyl]methyl}pyrimidin-4(3H)-one," with the CAS number 669749-45-5, is a complex organic compound characterized by its multi-ring structure, which includes a quinazoline and a pyrimidinone moiety. This compound features various functional groups, including an amino group, a methoxy group, and a sulfanyl group, contributing to its potential biological activity. The presence of the tetrazole ring suggests possible interactions with biological targets, making it of interest in medicinal chemistry. Its molecular structure indicates potential for diverse pharmacological properties, including anti-cancer or anti-inflammatory activities, although specific biological effects would depend on further empirical studies. The compound's solubility, stability, and reactivity would be influenced by its functional groups and overall molecular architecture, which are critical for its application in drug development and research.

<p>DCE_42 is a novel EZH2 inhibitor, it also displays significant anti-proliferation activity against lymphoma cell lines.</p>

CAS 669749-45-5

2-[(6-methoxy-4-methylquinazolin-2-yl)amino]-6-{[(1-phenyl-1H-tetrazol-5-yl)sulfanyl]methyl}pyrimidin-4(3H)-one

DCE_42

Ref: TM-T27130